Erectile Dysfunction: Clinical Trials

10 trials for Erectile Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 recruiting. 10 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Recruiting 10
Phase 33Recruiting 3
Phase 12Recruiting 2

Follow Erectile Dysfunction: new trials by email Literature Review of Erectile Dysfunction trials Research Report on Erectile Dysfunction

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy
Tadalafil 5 mg, Pelvic Floor Muscle Training (PFMT), Aerobic Exercise Program - Erectile Dysfunction Following Radical Prostatectomy, Prostate Cancer
Phase 2RecruitingSurgical Outcomes Research Centre (SOuRCe)642026-08-312026-10-23
Stem Cells for Erectile Dysfunction Post RALP
Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) at the doctor's office, Allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) in the OR, Placebo in the OR - Erectile Dysfunction, Prostate Cancer
Phase 1 / Phase 2RecruitingThe Methodist Hospital Research Institute402026-07-072026-07-10
A Single-Arm, Dose Escalation of an Intraurethral Alprostadil Paste for Erectile Dysfunction
ST-04 - Erectile Dysfunction (ED), Erectile Dysfunctions
Phase 2RecruitingRyan Flannigan, MD832026-05-012026-05-22
TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men
Pitavastatin 1-4 mg daily, Rosuvastatin 20-40 mg daily - Erectile Dysfunction Due to Arterial Disease, Atheroscleroses
Phase 2RecruitingLomonosov Moscow State University Medical Research and Educational Center1502026-03-052026-03-16
Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction
YN001 20mg Dose + 5% glucose injection, 5% glucose injection - Atherosclerotic Cardiovascular Disease (ASCVD), Erectile Dysfunction
Phase 2RecruitingBeijing Inno Medicine Co., Ltd.402026-02-042026-09-22
Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction
Umbilical Cord-Derived Mesenchymal Stem Cells, Umblical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes, Placebo Intracavernosal Injection - Erectile Dysfunction With Diabetes Mellitus
Phase 2 / Phase 3RecruitingAnkara City Hospital Bilkent902025-12-292026-03-18
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
Tadalafil 5mg, BZ371A, Oral Placebo - Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction
Phase 2RecruitingBiozeus Biopharmaceutical S.A.722023-11-222024-10-22
Efficacy of Tadalafil (5mg) For Treatment of Early Storage Symptoms and Erectile Dysfunction After Endoscopic Enucleation of Prostate
Tadalafil 5mg / Placebo - Erectile Dysfunction, Lower Urinary Tract Symptoms
Phase 2 / Phase 3RecruitingMansoura University1102023-04-012025-06-11
4-aminopyridine Treatment for Nerve Injury
4-Aminopyridine, Placebo - Nerve Injury, Prostate Cancer
Phase 2 / Phase 3RecruitingJohn Elfar702021-06-052025-12-17
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
PrimePro™/ PrimeMSK™ - Autoimmune Diseases, Cardiovascular Disorders
Phase 1 / Phase 2RecruitingThomas Advanced Medical LLC50002020-07-092022-04-29

Narrower conditions

Prostatic Neoplasms (4)  ·  Atherosclerosis (2)  ·  Cardiovascular Diseases (2)  ·  Alzheimer Disease (1)  ·  Autoimmune Diseases (1)  ·  Brain Diseases (1)  ·  COVID-19 (1)  ·  Cardiomyopathies (1)  ·  Central Nervous System Diseases (1)  ·  Coronary Artery Disease (1)  ·  Dementia (1)  ·  Diabetes Complications (1)  ·  Disease (1)  ·  Heart Diseases (1)

Broader conditions

Genital Diseases (10)  ·  Genital Diseases, Male (10)  ·  Male Urogenital Diseases (10)  ·  Sexual Dysfunctions, Psychological (10)  ·  Urogenital Diseases (10)  ·  Mental Disorders (9)  ·  Sexual Dysfunction, Physiological (9)  ·  Genital Neoplasms, Male (4)  ·  Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Prostatic Diseases (4)  ·  Urogenital Neoplasms (4)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)

Interventions

Tadalafil (3)  ·  4-Aminopyridine (1)  ·  Ambulatory Care Facilities (1)  ·  Glucose (1)  ·  Rosuvastatin Calcium (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)  ·  pitavastatin (1)

Sponsors

Ankara City Hospital Bilkent (1)  ·  Beijing Inno Medicine Co., Ltd. (1)  ·  Biozeus Biopharmaceutical S.A. (1)  ·  John Elfar (1)  ·  Lomonosov Moscow State University Medical Research and Educational Center (1)  ·  Mansoura University (1)  ·  Ryan Flannigan, MD (1)  ·  Surgical Outcomes Research Centre (SOuRCe) (1)  ·  The Methodist Hospital Research Institute (1)  ·  Thomas Advanced Medical LLC (1)

Countries

United States (3)  ·  Australia (1)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Egypt (1)  ·  Russia (1)  ·  Turkey (Türkiye) (1)

Top investigators

Daniel Steffens (1)  ·  Erkan Olcucuoglu, MD, Associate Professor (1)  ·  Ernst R Von Schwarz, MD, PhD (1)  ·  John Elfar, MD (1)  ·  Mahmoud Laymon, MD,MRCS (1)  ·  Rashid Sayyid, MD (1)  ·  Samet Senel, MD, Associate Professor (1)

Results publications

PMID 38773595